AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.
Company Details
- Address
- Carrer Baldiri Reixac, 4, Barcelona,catalonia 08028,spain
- Phone
- (514) 367 1212
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aelixtherapeutics.com
- Keywords
- Barcelona.
- HQ
- Barcelona, Catalonia
Aelix Therapeutics Questions
Aelix Therapeutics's helpline number is (514) 367 1212
Aelix Therapeutics's website is aelixtherapeutics.com
Aelix Therapeutics's LinkedIn profile is https://es.linkedin.com/company/aelix-therapeutics
Aelix Therapeutics's industry is
Biotechnology Research
Aelix Therapeutics's top competitors are
Oryzon Genomics Sa,
Nuage Therapeutics,
Splicebio,
Minoryx Therapeutics,
Accure Therapeutics,
Ona Therapeutics,
Onechain Immunotherapeutics,
Oxolife,
Highlight Therapeutics Sl,
Peptomyc.
Aelix Therapeutics's support email address is info@aelixtherapeutics.com
Aelix Therapeutics's categories are Biotechnology Research
